| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | European Journal of Heart Failure |
| Vol/bind | 23 |
| Udgave nummer | 3 |
| Sider (fra-til) | 417-419 |
| Antal sider | 3 |
| ISSN | 1388-9842 |
| DOI | |
| Status | Udgivet - 2021 |
Bibliografisk note
Funding Information:F.J.O. was financed by the Danish Heart Foundation (grant no.: 18-R125-A8534-22083), King Christian the 10th Foundation, Herlev & Gentofte Hospital, and Mrs. Asta Florida Boldings Memorial Grant during preparation of this manuscript. T.B.S. was financed by the Novo Nordisk Foundation, the Lundbeck foundation, and Herlev & Gentofte Hospital during the preparation of this manuscript. Conflict of interest: T.B.S.: Steering Committee member of the Amgen financed GALACTIC-HF trial; Advisory Board: Sanofi Pasteur, Amgen; speaker honorarium: Novartis, Sanofi Pasteur; research grant: GE Healthcare, Sanofi Pasteur. All other authors have nothing to disclose.